Fulgent Genetics: Q1 Earnings Insights


Fulgent Genetics FLGT reported its Q1 earnings results on Friday, May 5, 2023 at 07:00 AM.

Here's what investors need to know about the announcement.


Fulgent Genetics beat estimated earnings by 48.84%, reporting an EPS of $-0.22 versus an estimate of $-0.43.

Revenue was down $254.10 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.08 which was followed by a 2.87% drop in the share price the next day.

Here's a look at Fulgent Genetics's past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate -0.56 0.05 0.73 3.86
EPS Actual -0.48 0.32 0.78 5.08
Revenue Estimate 59.57M 91.36M 122.70M 270.85M
Revenue Actual 67.70M 105.66M 125.34M 320.27M

To track all earnings releases for Fulgent Genetics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!